APIXORA

APIXORA Strategic Investment

APIXORA Strategic Investment & Growth Roadmap

Building the New Global Standard for API Business

APIXORA is a global B2B platform that directly connects Korean pharmaceutical companies with global API manufacturers and authorized suppliers.

Beyond a simple product search service, APIXORA is designed to integrate and manage the entire API sourcing process on a single platform—from RFQs, competitive bidding, supplier matching, contracts, CDAs, sample management, KDMF/MFDS regulatory support, purchase orders (PO), proforma invoices (PI), to project management.

To accelerate platform growth and global expansion, APIXORA is seeking long-term strategic partnerships with investors and industry leaders who share our vision.

Investment Strategy

APIXORA's investment strategy goes beyond capital raising.

Our priority is to establish strategic investments and business partnerships that will jointly expand the global API supply chain, strengthen access to the Korean pharmaceutical market, and accelerate the growth of our digital platform ecosystem.

Potential Strategic Partners

  • Global pharmaceutical companies
  • Global API manufacturers and authorized suppliers
  • Strategic Investors (SI)
  • Venture Capital (VC)
  • Corporate Venture Capital (CVC)
  • Institutional investors
  • Global B2B platform and technology companies
  • Strategic partners in logistics, AI, and data solutions

No investment or partnership with any specific company has been finalized. APIXORA continuously evaluates potential partners based on long-term strategic synergy and sustainable growth opportunities.

Long-term Investment Roadmap

YearInvestment PhaseEquity Under ConsiderationTarget Enterprise Value (Illustrative)
2026Strategic Partner RoundUp to 10%Approx. KRW 20 Billion
2027Growth RoundAdditional Up to 20%Approx. KRW 40 Billion
2028Global Expansion RoundAdditional Up to 10%Approx. KRW 80 Billion
2029Global Business ExpansionSubject to Business NeedsTo Be Determined Based on Business Performance
2030IPO PreparationSubject to IPO StructureSubject to Market Valuation
Phase 1 · 2026

Strategic Partner Round

APIXORA will establish the foundation of its two-sided marketplace by simultaneously expanding its Korean pharmaceutical buyer network and its global API manufacturer and supplier ecosystem.

Key Objectives

  • Expand Korean pharmaceutical buyer network
  • Expand global API manufacturers and authorized suppliers
  • Activate RFQs and competitive bidding
  • Launch commercial transactions through the platform
  • Validate business model and revenue generation
  • Strengthen KDMF and MFDS regulatory support services
  • Digitize the entire API sourcing process

Investment Focus

  • Strategic partner investments
  • Consider secondary share transactions of up to 10%
  • Illustrative Target Enterprise Value: Approx. KRW 20 Billion

2026 Vision — Establish the market foundation of a digital platform connecting Korean pharmaceutical buyers with global API suppliers.

Phase 2 · 2027

Growth Round

Following successful market validation, APIXORA will significantly expand its user base, transaction volume, and commercial activities.

Key Objectives

  • Expand membership among major Korean pharmaceutical companies
  • Grow the global API manufacturer network
  • Increase recurring commercial projects
  • Develop AI-powered supplier recommendation systems
  • Strengthen platform competitiveness through transaction data
  • Expand KDMF registration projects
  • Establish sustainable revenue models

Investment Focus

  • Growth investment round
  • Consider additional secondary share transactions of up to 20%
  • Illustrative Target Enterprise Value: Approx. KRW 40 Billion

2027 Vision — Become Korea's leading digital platform for pharmaceutical API sourcing.

Phase 3 · 2028–2029

Global Expansion

Expand the proven Korean business model into international markets and establish a truly global API trading ecosystem.

Key Objectives

  • Enter Japan, Southeast Asia, the Middle East, and European markets
  • Expand global API manufacturers and authorized agents
  • Build country-specific regulatory databases
  • Enhance AI-driven supply chain intelligence
  • Activate global RFQs and multi-country competitive bidding
  • Secure overseas strategic partners
  • Establish a global API trading ecosystem

Investment Focus

  • Global expansion investment
  • Consider additional secondary share transactions of up to 10%
  • Illustrative Target Enterprise Value: Approx. KRW 80 Billion

2028–2029 Vision — Transform APIXORA into a leading global API trading platform.

Phase 4 · 2030

IPO Preparation

Based on stable commercial performance and a global supply network, APIXORA aims to begin formal preparations for an Initial Public Offering (IPO).

Key Objectives

  • Establish sustainable revenue streams
  • Expand global buyers and suppliers
  • Strengthen corporate governance
  • Build robust internal control and financial reporting systems
  • Enhance cybersecurity and data governance
  • Prepare for IPO requirements
  • Strengthen the APIXORA global brand

2030 Vision — Become one of the world's leading digital platforms for the pharmaceutical API industry.

Value Created by APIXORA

For Korean Pharmaceutical Companies

  • Access to competitive global API suppliers
  • Procurement cost reduction
  • Supply chain diversification
  • Transparent supplier comparison and competitive bidding
  • KDMF and MFDS regulatory support
  • End-to-end procurement management

For Global API Manufacturers & Suppliers

  • Direct access to the Korean pharmaceutical market
  • New buyer acquisition opportunities
  • Real-time RFQ opportunities
  • Korean regulatory and KDMF support
  • Integrated sales, contracting, and post-sales management

For Investors & Strategic Partners

  • High barriers to entry through pharmaceutical industry expertise
  • Two-sided marketplace connecting Korean buyers and global suppliers
  • Recurring B2B transaction-based business model
  • AI-powered API trading platform
  • Increasing enterprise value through accumulated transaction data
  • Highly scalable global expansion model

Investment & Partnership Opportunities

APIXORA is open to various forms of strategic collaboration, including:

  • Strategic equity investments
  • Business partnership-linked investments
  • Joint market expansion
  • Global supply chain collaboration
  • Strategic partnerships in AI, logistics, and data technologies
  • Long-term growth partnerships

Investment Inquiries

We welcome strategic partners and investors who share our vision of building the new global standard for API business.

Investment & Strategic Partnership — contact@apixora.com

Disclaimer

This roadmap is intended to present APIXORA's current business strategy and long-term growth vision.

The enterprise values presented herein are illustrative targets based on the successful achievement of each development phase and should not be interpreted as fixed valuations or investment terms. Actual investment terms, company valuation, ownership structure, and IPO plans will be determined based on business performance, financial results, market conditions, strategic considerations, and discussions with prospective investors.